1α,25-Dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 726-730

  Istfan, N W ^a   Person, K S ^a   Holick, M F ^a   Chen, T C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Fish oil; LNCaP cells; Prostate cancer; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; FISH OIL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; 1,25-DIHYDROXYVITAMIN D; CALCITRIOL; DRUG DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER; ANIMAL; DRUG EFFECT; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FISH OILS; G1 PHASE; HUMANS; MALE; PROSTATIC NEOPLASMS; S PHASE; VITAMIN D;

EID: 33947102616     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.011     Document Type: Article

References (27)

1. Huggins C., and Hodges C.V. Studies of prostatic cancer: effects of castrations, estrogen and androgen injections on serum phosphatases in metastatic carcinoma of prostate. Cancer Res. 1 (1941) 293-307
2. Shim M., and Cohen P. IGFs and human cancer regarding the risk of growth hormone therapy. Horm. Res. 51 Suppl. 3 (1999) 42-51
3. Armstrong B., and Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int. J. Cancer 15 (1975) 617-631
4. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res. 52 (1992) 2024s-2029s
5. Giovannucci E., Rimm E.B., Colditz G.A., Stampfer M.J., Ascherio A., Chute C.C., and Willett W.C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst. 85 (1993) 1571-1579
6. Leitzmann M.F., Stampfer M.J., Michaud D.S., Augustsson K., Colditz G.C., Willett W.C., and Giovannucci E.L. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am. J. Clin. Nutr. 80 (2004) 204-216
7. Brouwer I.A., Katan M.B., and Zock P.L. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J. Nutr. 134 (2004) 919-922
8. Hardman W.E. N-3 fatty acids and cancer therapy. J. Nutr. 134 Suppl. (2004) 3427S-3430S
9. Igawa T., Lin F.-F., Lee M.-S., Karan D., Batra S.K., and Lin M.-F. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. Prostate 50 (2002) 222-235
10. Fox P.L., and DiCorleto P.E. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science 241 (1988) 453-456
11. Istfan N.W., Chen Z.-Y., and Rex S. Fish oil slows S-phase progression and may cause an upstream shift of the DHFR replication origin ori-β in CHO cells. Am. J. Physiol. 283 (2002) C1009-C1024
12. Begg A.C., McNally N.J., Shrieve D.C., and Kaercher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6 (1985) 620-626
13. White R.A., and Terry N.H.A. A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine. Cytometry 13 (1992) 490-495
14. White R.A., Meistrich M.L., Pollack A., and Terry N.H.A. Simultaneous estimation of TG2 + M, TS and Tpot using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry. Cytometry 41 (2000) 1-8
15. Rex S., Kukuruzinska M., and Istfan N.W. Inhibition of DNA replication by fish oil treated cytoplasm is reversed by fish oil treated nuclear extract. Am. J. Physiol. (Cell Physiol.) 283 (2002) C1365-C1375
16. Chen Z.Y., and Istfan N.W. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostag. Leukotr. Fatty Acids 64 (2001) 67-73
17. Istfan N.W., Wan J., and Chen Z.Y. Fish oil and cell proliferation kinetics in a mammary tumor model. Adv. Exp. Med. Biol. 375 (1995) 149-156
18. 3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 139 (1998) 1197-1207
19. Terry P.D., Terry J.B., and Rohan T.E. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J. Nutr. 134 (2004) 3412S-3420S
20. Jump D.B. The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem. 277 (2002) 8755-8758
21. Grimaldi P.A. Fatty acid regulation of gene expression. Curr. Opin. Nutr. Metab. Care 4 (2001) 433-437
22. Vamceq J., and Latruffe N. Medical significance of peroxisome proliferators-activated receptors. Lancet 354 (1999) 141-148
23. Mueller E., Smith M., and Sarraf P. Effects of ligand activation of peroxisome proliferators-activated receptor gamma in human prostate cancer. Proc. Natl. Acad. Sci. 97 (2000) 10990-10995
24. Diep Q.N., Touyz R.M., and Schiffrin E.L. Docosahexaenoic acid, a peroxisome proliferators-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulating p38 mitogen activated protein kinase. Hypertension 36 (2000) 851-855
25. Hisatake J.L., IKezoe T., Carey M., Holden S., Tomoyasu S., and Koeffler H.P. Down-regulation of prostate specific antigen by ligands for peroxisome proliferators-activated receptor gamma in human prostate cancer. Cancer Res. 60 (2000) 5494-5498
26. Chambrier C., Bastard J.P., and Rieusset J. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferators-activated receptor gamma. Obes. Res. 10 (2002) 518-525
27. 3 and its nuclear receptor. J. Mol. Biol. 349 (2005) 248-260